Browse by Authors and Editors
Jump to: 2017 Number of items: 1. 2017Clark, Richard E., Polydoros, Fotios, Apperley, Jane F., Milojkovic, Dragana, Pocock, Christopher, Smith, Graeme, Byrne, Jenny L., de Lavallade, Hugues, O'Brien, Stephen G., Coffey, Tony, Foroni, Letizia and Copland, Mhairi (2017) A phase 2 trial of decreasing tyrosine kinase inhibitor dose in chronic myeloid leukaemia patients with stable major molecular response: data from the British DESTINY study. Lancet Haematology, 4 (7). pp. 310-316. ISSN S2352-3026(17)30066-2 |
